Abnormal developmental control of replication-timing domains in pediatric acute lymphoblastic leukemia. - Wikidata - awgldk - TriplyDB

Abnormal developmental control of replication-timing domains in pediatric acute lymphoblastic leukemia.

Abnormal developmental control of replication-timing domains in pediatric acute lymphoblastic leukemia.

http://www.wikidata.org/entity/Q36285367

about

The replication domain model: regulating replicon firing in the context of large-scale chromosome architecture Complex correlations: replication timing and mutational landscapes during cancer and genome evolution Cell cycle control in the early embryonic development of aquatic animal species The LMO2 oncogene regulates DNA replication in hematopoietic cells Genomic basis of aromatase excess syndrome: recombination- and replication-mediated rearrangements leading to CYP19A1 overexpression A chromatin structure-based model accurately predicts DNA replication timing in human cells Topologically associating domains are stable units of replication-timing regulation DNA replication timing Genetic variation in human DNA replication timing Dynamic changes in replication timing and gene expression during lineage specification of human pluripotent stem cells.Replication-timing boundaries facilitate cell-type and species-specific regulation of a rearranged human chromosome in mouse.Mouse Rif1 is a key regulator of the replication-timing programme in mammalian cells.Genome-wide Determination of Mammalian Replication Timing by DNA Content Measurement.3D chromatin conformation correlates with replication timing and is conserved in resting cells DNA replication timing, genome stability and cancer: late and/or delayed DNA replication timing is associated with increased genomic instability.Genome-wide copy number profiling of single cells in S-phase reveals DNA-replication domains.Back to the origin: reconsidering replication, transcription, epigenetics, and cell cycle control.LINEs of evidence: noncanonical DNA replication as an epigenetic determinant Stability of patient-specific features of altered DNA replication timing in xenografts of primary human acute lymphoblastic leukemia.Joint annotation of chromatin state and chromatin conformation reveals relationships among domain types and identifies domains of cell-type-specific expression.A role for DNA polymerase θ in the timing of DNA replication.Perturbations in the Replication Program Contribute to Genomic Instability in Cancer.DNA replication timing and higher-order nuclear organization determine single-nucleotide substitution patterns in cancer genomes.Computing interaction probabilities in signaling networks.DNA replication timing influences gene expression level.Murine esBAF chromatin remodeling complex subunits BAF250a and Brg1 are necessary to maintain and reprogram pluripotency-specific replication timing of select replication domains.Developmental control of replication timing defines a new breed of chromosomal domains with a novel mechanism of chromatin unfolding.The distribution of genomic variations in human iPSCs is related to replication-timing reorganization during reprogramming.Bacterial artificial chromosomes establish replication timing and sub-nuclear compartment de novo as extra-chromosomal vectors.Targeting ATR/CHK1 pathway in acute myeloid leukemia to overcome chemoresistance.Genome-wide analysis of replication timing by next-generation sequencing with E/L Repli-seq.CHK1 as a therapeutic target to bypass chemoresistance in AML.[How genomic approaches help the understanding of the initiation of DNA replication].Continuous-Trait Probabilistic Model for Comparing Multi-species Functional Genomic Data Developmental and cancer-associated plasticity of DNA replication preferentially targets GC-poor, lowly expressed and late-replicating regions

P2860

Q26825520-06453CD7-9972-4124-B8E9-D51ADF86BB73 Q26827533-FB45C9F0-D171-43B7-A758-42D02724740C Q28087148-6420D76B-2281-41B7-B729-7E34C05E88A4 Q28272026-AFD90964-5990-4D34-B22E-37C94802AC49 Q33587852-E6EC4E78-8C43-49D8-AE35-6E4B68B8BFBD Q33597313-955C9E08-E95C-453C-BACF-847F09523580 Q34448599-006556F4-96F0-4833-BC7D-76663E869936 Q34654036-13B776D3-9001-48AF-A4F4-39AE32C34E53 Q35178159-D792B39A-3A00-4191-9490-931B987CE05A Q35876030-25057713-18E2-40B7-97CE-994AA724C4B9 Q36231670-CCB9C36F-4451-4533-B35D-EBBB06D2BED5 Q36234013-29E0CA94-BA77-4417-975B-D1AFCE7E5156 Q36277962-8AAC3520-1838-4699-BDE9-9442F94C8C00 Q36341542-1B1518AF-9F37-4179-970C-93A13C032DA2 Q36736144-346E05A0-4BD6-4EF4-BC6D-0A492C47CD97 Q36740913-5651FC85-7647-48C6-8948-413DBEC23FBA Q36796433-8315351E-41C3-4D02-896C-47A1B7EB923D Q37404117-10C3CF43-B930-4FD1-BBF5-CCE1279B8A31 Q38691997-5A5C6348-1EE2-49F7-A1A2-86817010A83E Q38910234-22FC766E-C675-433F-B885-4A121B05DA65 Q38978675-E77953A4-D375-4B97-9CFB-1A968AA08B06 Q39354510-E92718E8-239D-42D7-BCF8-89EEE1FA2AE8 Q40015551-CC71F2FE-4C3A-43C6-807C-DE93EA7F373C Q40299013-75FFF92D-0413-413C-8D9D-EE9B8D26A94C Q40967205-C7BB9E54-225C-4F73-B310-5BB0314D7518 Q41878970-8302B47D-8230-44AF-B3C0-C16917C533FA Q42391391-A16A8FC3-9C63-4083-8565-CE5A7B90502E Q42792252-9A49852B-D501-460F-9AF5-475C88D280A0 Q47558882-2FE4A9E3-969F-4A03-8B71-64F1BD1D797B Q48150734-0DE6C0B9-2818-441A-BE3F-E4B791D909D0 Q51415384-01762E18-28BA-4353-91F5-3E4C927FFCB0 Q51510125-CA1AB173-EA2C-449D-8DCA-3A7C97218F2E Q52712164-F12E4F84-4DCF-4330-82F5-0B59407C224C Q56333987-BD4AB5BC-549E-4717-8AB4-3417FD2BF3D5 Q58762230-EDDF75C1-130D-4C74-977A-24F1AC5487E7

P2860

Abnormal developmental control of replication-timing domains in pediatric acute lymphoblastic leukemia.

http://www.wikidata.org/entity/Q36285367

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Abnormal developmental control ...... acute lymphoblastic leukemia.

@ast

Abnormal developmental control ...... acute lymphoblastic leukemia.

@en

type

label

Abnormal developmental control ...... acute lymphoblastic leukemia.

@ast

Abnormal developmental control ...... acute lymphoblastic leukemia.

@en

prefLabel

Abnormal developmental control ...... acute lymphoblastic leukemia.

@ast

Abnormal developmental control ...... acute lymphoblastic leukemia.

@en

P1433

Q36285367-12E5AC5C-8FAA-47BD-A35A-0B944AB55132

P1476

Q36285367-439081E2-8AFA-484C-83AF-2CAAF1805039

P2093

Q36285367-2712CE21-F464-452A-B802-51695CEB3764

Q36285367-398B81AB-177A-4EB0-93E0-3CFD482EE598

Q36285367-4A4F58BA-358F-4A01-95AB-FEBE112C041E

Q36285367-50141C13-C0AF-4228-AEC6-BA674FDEC4D1

Q36285367-80459D45-84E9-43C3-8B17-9FB871921891

Q36285367-EA504DB7-B282-4C55-8A24-6FC8F2D79A80

Q36285367-EBC917FD-5A5C-4268-8CAC-5F21D2D524EC

P2860

Q36285367-0CE901E8-FD14-473E-9291-9DE924ACC4D5

Q36285367-0D012A43-E18A-4318-9595-280CAD61741E

Q36285367-20F18D2E-2441-4879-9E12-8D4D9BA2D810

Q36285367-215B924C-4FA6-44A9-A73F-21B841D287D5

Q36285367-22D2E89C-52FD-44EA-A322-8FD7DD79A99E

Q36285367-26A18164-6097-4278-8F95-B2D2285C1F4C

Q36285367-27BF8CA1-3348-489E-8B5C-2027759E2325

Q36285367-2CD651BD-AE4B-488D-AECD-E0B091F5C3B9

Q36285367-2D4D72E1-70C9-44D5-8CE2-872FA0AB28B7

Q36285367-2E95BECA-981D-42B9-AA41-64FF4F72039E

P304

Q36285367-7F98B63B-2E8C-496B-A662-10457C953D74

P31

Q36285367-A88BCF1F-2DA7-4E2A-BACC-C564A6F317EF

P356

Q36285367-C418E31B-D4F5-4CD6-9C98-B5E8217D8C82

P433

Q36285367-5F4D32FB-9273-4F79-93DB-EDB845B3FD48

P478

Q36285367-49D3A61D-B88C-454E-BFF2-2B099F653F88

P50

Q36285367-B1130928-3E0C-41FF-8CA1-5D4569C21FC0

Q36285367-DA8F720B-C164-4145-958F-8E2C1AAB9635

P577

Q36285367-5608082C-DCA6-4B20-A8D3-AC9F9070657A

P5875

Q36285367-294D39BA-D9D0-4CD9-BC5D-1A6945FB6AA7

P698

Q36285367-D3A10D56-E1FC-4191-B333-1D7D6B16B63A

P921

Q36285367-BC534479-0A5A-4A42-916A-91CFA1460991

P932

Q36285367-9739C9D9-D2B5-464B-A13F-2E7E3054907D

P356

P1433

Genome Research

P1476

Abnormal developmental control ...... acute lymphoblastic leukemia.

@en

P2093

Benjamin D Pope

http://www.w3.org/2001/XMLSchema#string

Dana Battaglia

http://www.w3.org/2001/XMLSchema#string

David M Gilbert

http://www.w3.org/2001/XMLSchema#string

James W Shirley

http://www.w3.org/2001/XMLSchema#string

Meenakshi Devidas

http://www.w3.org/2001/XMLSchema#string

Quinton Buckley

http://www.w3.org/2001/XMLSchema#string

Tyrone Ryba

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning and expression of two distinct human chondroitin 4-O-sulfotransferases that belong to the HNK-1 sulfotransferase gene family

Molecular cloning, expression, and chromosomal mapping of human chondroitin 4-sulfotransferase, whose expression pattern in human tissues is different from that of chondroitin 6-sulfotransferase

Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene

Comprehensive mapping of long-range interactions reveals folding principles of the human genome

The cluster of BTN genes in the extended major histocompatibility complex

Deregulation of the carbohydrate (chondroitin 4) sulfotransferase 11 (CHST11) gene in a B-cell chronic lymphocytic leukemia with a t(12;14)(q23;q32)

BTN1A1, the mammary gland butyrophilin, and BTN2A2 are both inhibitors of T cell activation

Frontline: Characterization of BT3 molecules belonging to the B7 family expressed on immune cells

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

Global reorganization of replication domains during embryonic stem cell differentiation

P304

1833-1844

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1101/GR.138511.112

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Brian J. Druker

P577

2012-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225044450

http://www.w3.org/2001/XMLSchema#string

P698

22628462

http://www.w3.org/2001/XMLSchema#string

P921

P932

3460179

http://www.w3.org/2001/XMLSchema#string